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Introduction
Atrial natriuretic peptide (ANP), B-type natriuretic peptide (BNP) and C-type natriuretic peptide (CNP) are members of the natriuretic peptide family of bioactive peptides best known for their role in the regulation of blood pressure and cardiovascular homeostasis [1, 2] . The cellular responsiveness of natriuretic peptides is manifested through the specific cell surface receptors in different target tissues [1] . Cloning and expression of cDNAs led to the identification and characterization of the primary structure of three distinct subtypes of natriuretic peptide receptors (NPRs), which are currently designated as NPR-A and, NPR-B, and NPR-C [1] . ANP and BNP show the highest binding affinity for the type A particulate guanylate cyclase-coupled receptor (GC-A, NPR-A), whereas CNP binds the type B particulate guanylate cyclase-coupled receptor (GC-B, NPR-B) [3, 4] .
Most of the physiological actions of natriuretic peptides are mediated by these GC receptors through the generation of the second messenger cyclic guanosine monophosphate (cGMP). All three natriuretic peptides also bind the natriuretic peptide clearance receptor, natriuretic peptide receptor-C (NPR-C), which lacks guanylate cyclase activity primarily acting to control the local concentrations of all three natriuretic peptides through receptor mediated internalization and degradation [5, 6] .
Autoradiography has identified ANP in the Type II alveolar epithelial cells of rat lung, and NPR-A is expressed in various tissues including lung [7] [8] [9] , suggesting the possibility that lung tissue is a target organ. In effect, ANP relaxes guinea pig [10, 11] , rat [10] , bovine [12] and human [13] airway smooth muscle in vitro. In humans, exogenous ANP reverses airway hyperreactivity when given intravenously or by inhalation [14, 15] and has also been shown to modify bronchial reactivity to inhaled histamine [16] , propranolol [17] , and nebulized water [18] .
BNP shows a potent binding affinity for NPR-A [3, 4] . This finding suggests that BNP might have a role on airway smooth muscle in the same manner as does ANP. In effect, BNP relaxes guinea pig tracheal smooth muscle in vitro [19] and is effective in preventing ovalbumin-induced bronchoconstriction and microvascular leakage in guinea pigs in vivo [20] . In spite of these facts and M A N U S C R I P T
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4 the documentation that BNP levels are elevated at least in patients with pulmonary disease and right ventricular dysfunction [21] , published studies on BNP in human airways in vitro are still lacking in the literature.
Therefore, the aim of this study was to investigate the effects of BNP on human isolated bronchi constriction induced by carbachol and histamine.
Considering the efficacy of BNP in preventing ovalbumin-induced bronchoconstriction in guinea pigs [20] , we also tested the effect of BNP in passively sensitized human airways in vitro.
Materials and Methods

Tissue Preparations
Macroscopically normal airways, taken from an area as far as possible from the malignancy and dissected free of parenchyma, were obtained from 6 patients undergoing surgery for lung cancer but without a history of chronic airway disease. They were immediately placed into oxygenated Krebs-Henseleit buffer solution (NaCl, 119.0 mM; KCl, 5.4 mM; CaCl2, 2.5 mM; KH2PO4 mM, 1.2 mM; MgSO4, 1.2 mM; NaHCO3, 25.0 mM; glucose, 11.7 mM) containing the cyclooxygenase inhibitor indomethacin, (5.0 μM), and transported to the laboratory. None of the patients were chronically treated with theophylline, ß 2 -adrenoceptor agonists, corticosteroids or anticholinergic drugs. Preoperative lung function parameters were generally normal. Serum IgE levels on the day of surgery were determined for all patients to ensure that the tissues had not been sensitized prior to our interventions; they were always in the normal range. Samples were rotated overnight at room temperature in tubes containing Krebs-Henseleit buffer solution in the presence of 10% vol -1 serum from healthy and non-asthmatic patients with serum IgE levels in the normal range (nonsensitized rings) or in the presence of 10% vol -1 sensitizing serum from asthmatic patients (passively sensitized rings). The sensitizing serum was prepared from the whole blood of patients suffering from atopic asthma (total IgE >250 u ml -1 , and specific IgE antibodies against common aeroallergens) during an exacerbation. Passive sensitization of human airway smooth muscle has been described previously [22] . Sera were not pooled but rozen at -80°C M A N U S C R I P T
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5 in 200-ml aliquots until required. The next morning, after removal of adhering fat and connective tissues, bronchial rings with intact epithelium were transferred into 10 ml organ baths containing Krebs-Henseleit buffer (37°C) and continuously aerated with a 95:5% mixture of O 2 :CO 2 .
Tension measurements
Bronchial rings were mounted on hooks where one hook was attached with thread to a stationary rod and the other hook tied with thread to an isometric force displacement transducer. Bronchial rings were allowed to equilibrate for 90 min containing modified Krebs-Henseleit buffer, which was changed every 
Drugs
Acetylcholine, carbachol, histamine and BNP were obtained from Sigma (St.
Louis, USA). All drugs were dissolved in KH solution.
Results
Baseline characteristics of the bronchial rings
There was no significant difference (P>0.05) neither in nonsensitized, nor in 
Effect of carbachol and histamine on isolated bronchial rings
Carbachol induced a concentration-dependent contraction without statistical differences in the Emax or EC 70 in each group of bronchi (sensitized and nonsensitized) ( figure 2 ).
The effect of BNP was significantly more evident on carbachol-contracted passively sensitized bronchi (P<0.05) (Emax, %: 11.31±2.22; pD2: 
Discussion
The ANP level is significantly increased during severe asthma attacks, suggesting that ANP might have important bronchoprotective effects in asthma [23] . Also BNP levels are elevated in patients with pulmonary disease, at least in those with concomitant right ventricular dysfunction [21] . Moreover, elevated BNP concentrations resulting from pulmonary hypertension secondary to end-stage lung disease have been reported [24] even in the absence of left ventricular failure [25] . Unfortunately, the pathophysiologic consequences of these elevated concentrations are not completely understood, although there is a growing, but still poor and sometimes contrasting, evidence documenting that natriuretic peptide hormones play an important role in several biologic pulmonary activities, such as vasodilatation, bronchorelaxation, pulmonary permeability, and surfactant production and action [26] . In particular, there is documentation that ANP produces significant bronchodilation when given intravenously to both normal [27] and asthmatic subjects [13] and by inhalation in high doses in asthmatics [28] . Moreover, recently it has been documented that human recombinant BNP (nesiritide) is a potent bronchodilator in asthmatic patients [29] .
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Our results demonstrate that, at least in human isolated bronchi, BNP is ineffective in relaxing smooth muscle contracted by carbachol either in nonsensitized and sensitized preparations, whereas it shows a weak relaxant activity in sensistized bronchial rings contracted by histamine. This finding contrasts with the documentation that BNP elicits a potent bronchodilator effect in guinea pigs [19, 20] . Nonetheless, it must be mentioned that results from animal models cannot necessarily be applied to humans since BNP structures are highly diverse among species [1] .
It is difficult to explain the discrepancy between our in vitro data and the in vivo effects observed in asthmatic patients. We completely agree with Candenas et al. [30] and Labat et al. [31] , who suggested that there are no receptors for BNP on human airway smooth muscle and, consequently the We must highlight that we have used isolated bronchi from non atopic patients undergoing surgery because of lung cancer, whereas human recombinant BNP (nesiritide) is a potent bronchodilator in asthmatic patients [29] . These findings fit with the observation of Ohbayashi et al. [20] , who reported that ANP and BNP failed to relax guinea pig airways but both peptides inhibited antigen-induced bronchoconstriction in sensitized animals, suggesting that natriuretic peptide receptors might be expressed on airway smooth muscle during an inflammatory process.
For this reason, we have also explored if the effects of BNP might be modified by airway passive sensitization. In effect, we observed that BNP was more effective in passively sensitized airways contracted with histamine when compared with nonsensitized airways, although the broncholytic effect was weak (about 50%) when compared with that induced by papaverine. It must be mentioned that the in vitro model of passively sensitized human airways,
i.e. the incubation of isolated airways with IgE-rich serum obtained from atopic individuals, closely mimics features of bronchial hyperresponsiveness [22, 33] , a central abnormality in patients with asthma. It has been suggested that passive immune sensitization of human tissue confers an inherent change in the contractility of airway smooth muscle that may contribute to hyperresponsiveness, which could induce mast cell degranulation [33] .
In our opinion, the discrepancy between the lack of a true broncholytic activity of BNP in passively sensitized airways that we have observed and the documentation that IV human recombinant BNP is an effective bronchodilator in patients with asthma can be justified by the fact that BNP does not act as a true bronchodilator and it is likely that the effect recorded in asthmatic subjects must be linked to different actions than the simple bronchodilation. As correctly stressed by Ohbayashi et al. [20] , airway microvascular leakage followed by airway inflammation and plasma exudation into the airway is one of the most difficult factors complicating asthmatic conditions [34, 35] .
Therefore, the reduction of microvascular leakage with plasma exudation into the airway may be a more valuable antiasthmatic strategy than the bronchodilator effect. In effect, there is documentation that natriuretic peptide hormones elicit significant potent inhibitory effects on antigen-induced microvascular leakage [20] . Alternatively, one could postulate that this discrepancy may depend on the activation of natriuretic peptide receptors that are not located on airway smooth muscle and, consequently, the observed effect might be due to an indirect consequence of BNP. In effect, natriuretic peptide-release of NO by other lung cells, such as macrophages and epithelial cells may play a role in bronchodilation [36] .
In conclusion this study suggests that BNP only induces a modest relaxant effect on human airway smooth muscle, although we believe that further studies are needed to investigate its real role in asthma and, likely, COPD. 
